TY - JOUR
T1 - The reporting checklist for Chinese patent medicine guidelines
T2 - RIGHT for CPM
AU - Li, Xuanlin
AU - Huang, Lin
AU - Wang, Liaoyao
AU - Jin, Xin
AU - Zhou, Qi
AU - Ma, Yanfang
AU - Wang, Qi
AU - Wang, Tengyue
AU - Hu, Xuanming
AU - Ye, Ding
AU - Mao, Yingying
AU - Xie, Zhijun
AU - Chen, Yaolong
AU - Wen, Chengping
N1 - Funding Information:
The RIGHT for CPM project is funded by the Project of Science and Technology Plan of Zhejiang Province (2023C03040).
Publisher Copyright:
© 2023 The Author(s). Published by Elsevier Ltd.
PY - 2024/1
Y1 - 2024/1
N2 - Existing reporting checklists lack the necessary level of detail and comprehensiveness to be used in guidelines on Chinese patent medicines (CPM). This study aims to develop a reporting guidance for CPM guidelines based on the Reporting Items of Practice Guidelines in Healthcare (RIGHT) statement. We extracted information from CPM guidelines, existing reporting standards for traditional Chinese medicine (TCM), and the RIGHT statement and its extensions to form the initial pool of reporting items for CPM guidelines. Seventeen experts from diverse disciplines participated in two rounds of Delphi process to refine and clarify the items. Finally, 18 authoritative consultants in the field of TCM and reporting guidelines reviewed and approved the RIGHT for CPM checklist. We added 16 new items and modified two items of the original RIGHT statement to form the RIGHT for CPM checklist, which contains 51 items grouped into seven sections and 23 topics. The new and revised items are distributed across four sections (Basic information, Background, Evidence, and Recommendations) and seven topics: title/subtitle (one new and one revised item), Registration information (one new item), Brief description of the health problem (four new items), Guideline development groups (one revised item), Health care questions (two new items), Recommendations (two new items), and Rationale/explanation for recommendations (six new items). The RIGHT for CPM checklist is committed to providing users with guidance for detailed, comprehensive and transparent reporting, and help practitioners better understand and implement CPM guidelines.
AB - Existing reporting checklists lack the necessary level of detail and comprehensiveness to be used in guidelines on Chinese patent medicines (CPM). This study aims to develop a reporting guidance for CPM guidelines based on the Reporting Items of Practice Guidelines in Healthcare (RIGHT) statement. We extracted information from CPM guidelines, existing reporting standards for traditional Chinese medicine (TCM), and the RIGHT statement and its extensions to form the initial pool of reporting items for CPM guidelines. Seventeen experts from diverse disciplines participated in two rounds of Delphi process to refine and clarify the items. Finally, 18 authoritative consultants in the field of TCM and reporting guidelines reviewed and approved the RIGHT for CPM checklist. We added 16 new items and modified two items of the original RIGHT statement to form the RIGHT for CPM checklist, which contains 51 items grouped into seven sections and 23 topics. The new and revised items are distributed across four sections (Basic information, Background, Evidence, and Recommendations) and seven topics: title/subtitle (one new and one revised item), Registration information (one new item), Brief description of the health problem (four new items), Guideline development groups (one revised item), Health care questions (two new items), Recommendations (two new items), and Rationale/explanation for recommendations (six new items). The RIGHT for CPM checklist is committed to providing users with guidance for detailed, comprehensive and transparent reporting, and help practitioners better understand and implement CPM guidelines.
KW - Chinese patent medicine
KW - Reporting guideline
KW - RIGHT statement
KW - Traditional Chinese Medicine
UR - http://www.scopus.com/inward/record.url?scp=85178416066&partnerID=8YFLogxK
U2 - 10.1016/j.phrs.2023.107015
DO - 10.1016/j.phrs.2023.107015
M3 - Journal article
C2 - 38036197
AN - SCOPUS:85178416066
SN - 1043-6618
VL - 199
JO - Pharmacological Research
JF - Pharmacological Research
M1 - 107015
ER -